Sanofi Group

GPTKB entity

Statements (83)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:CEO gptkb:Paul_Hudson
gptkbp:country gptkb:France
gptkbp:founded 1973
gptkbp:foundedBy gptkb:Elf_Aquitaine
gptkbp:headquartersLocation gptkb:Paris,_France
https://www.w3.org/2000/01/rdf-schema#label Sanofi Group
gptkbp:industry Pharmaceuticals
gptkbp:language gptkb:French
English
gptkbp:legalForm Société Anonyme
gptkbp:listedOn gptkb:Euro_Stoxx_50
gptkb:CAC_40
NYSE (ADR: SNY)
gptkbp:marketCap ~€110 billion (2024)
gptkbp:memberOf gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
gptkbp:netIncome €6.72 billion (2023)
gptkbp:notableAcquisition gptkb:Synthorx_(2019)
gptkb:Genzyme_(2011)
Bioverativ (2018)
Principia Biopharma (2020)
Translate Bio (2021)
Kadmon Holdings (2021)
gptkbp:numberOfEmployees ~91,000
gptkbp:parentCompany nan
gptkbp:predecessor gptkb:Sanofi-Synthélabo
gptkb:Aventis
gptkbp:product gptkb:Myozyme
gptkb:Stilnox
gptkb:Allegra
gptkb:Aprovel
gptkb:Enterogermina
gptkb:Vaxigrip
gptkb:Maalox
gptkb:Amaryl
gptkb:Aubagio
gptkb:Clexane
gptkb:Dupixent
gptkb:Kevzara
gptkb:Lantus
gptkb:Menactra
gptkb:Pentacel
gptkb:Plavix
gptkb:Praluent
gptkb:Toujeo
Flagyl
Buscopan
Doliprane
Essentiale
Magne B6
No-Spa
Clamoxyl
Depakine
Fervex
Hexyon
Lasilactone
Polio vaccines
Rabies vaccines
Solian
Telfast
Yellow fever vaccines
gptkbp:products Consumer healthcare products
Vaccines
Pharmaceutical drugs
gptkbp:researchInterest Oncology
Vaccines
Immunology
Diabetes
Consumer healthcare
Multiple sclerosis
Rare diseases
Cardiovascular diseases
gptkbp:revenue €43.07 billion (2023)
gptkbp:servesArea Worldwide
gptkbp:stockExchange gptkb:Euronext_Paris
gptkbp:stockSymbol SAN
gptkbp:subsidiary gptkb:Sanofi_Pasteur
gptkb:Genzyme
gptkb:Chattem
gptkbp:website https://www.sanofi.com/
gptkbp:bfsParent gptkb:Sanofi_Egypt
gptkbp:bfsLayer 7